Resmed (RMD) Institutional Ownership
13F filers reported holding 71.6% of Resmed (RMD) shares as of Jun 30, 2026, across 899 filers.
4 figures withheld by our checks. Each blank figure names its reason.
- Held by 13F filers
- 71.6%
- Jun 30, 2026
- 13F filers
- 899
- quarter ended Jun 30, 2026
- 13F value
- $19.6B
- 100.6M shares
Is the smart money (institutions and insiders) accumulating or distributing? One lagging input, not a buy signal.
| Date | Name | Role | Type | Shares | Price** | SEC filing |
|---|---|---|---|---|---|---|
| Nov 11, 2026 | Farrell Michael J. | Chairman and CEO | Disposed · Tax withholding | 3,466 | $234.11 | ↗ |
| Nov 11, 2026 | Farrell Michael J. | Chairman and CEO | Disposed · Tax withholding | 2,210 | $234.11 | ↗ |
| Nov 11, 2026 | Farrell Michael J. | Chairman and CEO | Disposed · Tax withholding | 2,436 | $234.11 | ↗ |
| Nov 11, 2026 | Bloomer Aaron | Chief Financial Officer | Disposed · Tax withholding | 1,095ResMed Common Stock | $234.11 | ↗ |
| Nov 11, 2026 | FARRELL PETER C | director | Disposed · Tax withholding | 169 | $234.11 | ↗ |
| Nov 11, 2026 | De Witte Jan | director | Disposed · Tax withholding | 60ResMed Common Stock | $234.11 | ↗ |
| Nov 11, 2026 | Gill Harjit | director | Disposed · Tax withholding | 36 | $234.11 | ↗ |
| Nov 11, 2026 | Rider Michael J | Global General Counsel | Disposed · Tax withholding | 547ResMed Common Stock | $234.11 | ↗ |
| Nov 11, 2026 | Rider Michael J | Global General Counsel | Disposed · Tax withholding | 499ResMed Common Stock | $234.11 | ↗ |
| Nov 11, 2026 | Rider Michael J | Global General Counsel | Disposed · Tax withholding | 724ResMed Common Stock | $234.11 | ↗ |
| Nov 11, 2026 | Rider Michael J | Global General Counsel | Disposed · Tax withholding | 173ResMed Common Stock | $234.11 | ↗ |
| Nov 9, 2026 | Farrell Michael J. | Chairman and CEO | Acquired · Option exercise | 683 | $146.34 | ↗ |
| Nov 9, 2026 | Farrell Michael J. | Chairman and CEO | Acquired · Option exercise | 4,310 | $146.34 | ↗ |
| Nov 9, 2026 | Farrell Michael J. | Chairman and CEO | Disposed · Open-market sale | 4,993 | $235.35 | ↗ |
| Nov 9, 2026 | Farrell Michael J. | Chairman and CEO | Disposed · Option exercise | 683 | — | ↗ |
| Nov 9, 2026 | Farrell Michael J. | Chairman and CEO | Disposed · Option exercise | 4,310 | — | ↗ |
| Oct 23, 2026 | Rider Michael J | Global General Counsel | Disposed · Open-market sale | 400ResMed Common Stock | $255.00 | ↗ |
| Oct 7, 2026 | Farrell Michael J. | Chairman and CEO | Acquired · Option exercise | 4,991 | $146.34 | ↗ |
| Oct 7, 2026 | Farrell Michael J. | Chairman and CEO | Disposed · Open-market sale | 4,991 | $226.33 | ↗ |
| Oct 7, 2026 | Farrell Michael J. | Chairman and CEO | Disposed · Option exercise | 4,991 | — | ↗ |
* Holdings as reported for Jun 30, 2026, 140 days old; funds file up to 45 days after each quarter-end, so the newest complete quarter runs 45 to 135 days behind.
** A price of “—” marks an option exercise, RSU vest or a filing without a usable per-share price, not a $0 trade.
Common questions
How much of Resmed do institutions hold?
13F filers reported holding 71.6% of Resmed's shares as of Jun 30, 2026, across 899 filers.
How many 13F filers hold Resmed?
Resmed was held by 899 13F filers as of Jun 30, 2026.
Not investment advice.

